<DOC>
	<DOCNO>NCT01189812</DOCNO>
	<brief_summary>The investigator hypothesize patient receive citalopram combination lithium great reduction depressive symptom patient receive citalopram combination placebo .</brief_summary>
	<brief_title>Safety Efficacy Study Citalopram Lithium Treatment Depressive Mood Disorder Symptoms</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Mood Disorders</mesh_term>
	<mesh_term>Personality Disorders</mesh_term>
	<mesh_term>Borderline Personality Disorder</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>1875 year age Meets criterion Major Depressive Disorder , Dysthymia , Depression Not Otherwise Specified Borderline Personality Disorder Ability speak , read understand English Language provide write informed consent Current , unstable significant medical condition illness History Thyroid disorder , seizure disorder , tumor CNS condition predispose patient risk seizure Pregnant lactating female Abnormal clinical laboratory test result Intolerance hypersensitivity SSRIs lithium History current diagnosis bipolar mood disorder , psychosis , schizophrenia dementia Certain mediation use prior study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>hopelessness</keyword>
	<keyword>alone</keyword>
	<keyword>sad</keyword>
	<keyword>troubled</keyword>
	<keyword>depression</keyword>
</DOC>